MelissaLauren(Bryan)JavellanaMD
Obstetrics & Gynecology • Kansas City, KSGynecologic Oncology
Assistant Professor
Dr. Javellana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3901 Rainbow Blvd.
3015 Wescoe MS 2028
Kansas City, KS 66160
Education & Training
University of ChicagoFellowship, Gynecologic Oncology, 2019 - 2022- University of ChicagoResidency, Obstetrics and Gynecology, 2015 - 2019
University of Illinois College of MedicineClass of 2015
Certifications & Licensure
MO State Medical License 2022 - 2026
KS State Medical License 2022 - 2025
IL State Medical License 2017 - 2023- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Utilization and outcomes of serial cervical cancer screening in a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in a non-Medicaid expansion state.Rubina Ratnaparkhi, Ahmed Ismail, Hope Krebill, Ian Cook, Melissa Javellana
Cancer Causes & Control. 2024-12-16 - Functional Analysis of RE1 Silencing Transcription Factor as a Putative Tumor Suppressor in Human Endometrial Cancer.Yasmin Abedin, Paige Minchella, Riley Peterson, Francesca Gonnella, Amanda Graham
International Journal of Molecular Sciences. 2024-09-07 - 1 citationsEvaluation of Homologous Recombination Deficiency in Ovarian Cancer.Rubina Ratnaparkhi, Melissa Javellana, Andrea Jewell, Lori Spoozak
Current Treatment Options in Oncology. 2024-02-01
Professional Memberships
- Society of Gynecologic OncologyMember
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
